Su Jong Yu

8.7k total citations
280 papers, 6.2k citations indexed

About

Su Jong Yu is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Su Jong Yu has authored 280 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 181 papers in Epidemiology, 180 papers in Hepatology and 42 papers in Molecular Biology. Recurrent topics in Su Jong Yu's work include Liver Disease Diagnosis and Treatment (143 papers), Hepatocellular Carcinoma Treatment and Prognosis (99 papers) and Hepatitis B Virus Studies (77 papers). Su Jong Yu is often cited by papers focused on Liver Disease Diagnosis and Treatment (143 papers), Hepatocellular Carcinoma Treatment and Prognosis (99 papers) and Hepatitis B Virus Studies (77 papers). Su Jong Yu collaborates with scholars based in South Korea, Ethiopia and United States. Su Jong Yu's co-authors include Jung‐Hwan Yoon, Yoon Jun Kim, Jeong‐Hoon Lee, Eun Ju Cho, Yun Bin Lee, Yuri Cho, Dong Ho Lee, Jeong‐Ju Yoo, Dong Hyeon Lee and Jeong Min Lee and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Su Jong Yu

265 papers receiving 6.1k citations

Peers

Su Jong Yu
Helen L. Reeves United Kingdom
Li Xu China
Rong Guo China
David J. Pinato United Kingdom
Do Young Kim South Korea
Su Jong Yu
Citations per year, relative to Su Jong Yu Su Jong Yu (= 1×) peers Kazuhiro Nouso

Countries citing papers authored by Su Jong Yu

Since Specialization
Citations

This map shows the geographic impact of Su Jong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Jong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Jong Yu more than expected).

Fields of papers citing papers by Su Jong Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Jong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Jong Yu. The network helps show where Su Jong Yu may publish in the future.

Co-authorship network of co-authors of Su Jong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Su Jong Yu. A scholar is included among the top collaborators of Su Jong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Jong Yu. Su Jong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sohn, Won, Young‐Sun Lee, Soon Sun Kim, et al.. (2025). KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025. Clinical and Molecular Hepatology. 31(Suppl). S1–S31. 13 indexed citations
2.
Chung, Sung Won, Min Kyung Park, Xiao Zhang, et al.. (2024). The Predictive Value of Time‐Varying Noninvasive Scores on Long‐Term Prognosis of NAFLD in South Korea. Canadian Journal of Gastroenterology and Hepatology. 2024(1). 5667986–5667986.
3.
Kim, Jae Hyun, Jeong Hee Yoon, Junghoan Park, et al.. (2024). No-Touch Radiofrequency Ablation Using Twin Cooled Wet Electrodes for Recurrent Hepatocellular Carcinoma Following Locoregional Treatments. Korean Journal of Radiology. 25(5). 438–438. 1 indexed citations
4.
Kim, Seung Up, Hyun Woong Lee, Han Ah Lee, et al.. (2024). FRI-397 A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B. Journal of Hepatology. 80. S774–S775.
5.
Chung, Goh Eun, Eun Ju Cho, Min Joo Kim, et al.. (2023). Association between the fatty liver index and the risk of fracture among individuals over the age of 50 years: a nationwide population-based study. Frontiers in Endocrinology. 14. 1156996–1156996. 3 indexed citations
7.
Cho, Eun Ju, Su‐Min Jeong, Goh Eun Chung, et al.. (2023). Gamma-glutamyl transferase and risk of all-cause and disease-specific mortality: a nationwide cohort study. Scientific Reports. 13(1). 1751–1751. 20 indexed citations
8.
Park, Min Kyung, Dong Ho Lee, Bo Yun Hur, et al.. (2023). Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score. Radiology. 307(5). e222106–e222106. 11 indexed citations
9.
Jang, Heejoon, Joon Yeul Nam, Yun Bin Lee, et al.. (2021). Yttrium-90 Radioembolization Is Associated with Better Clinical Outcomes in Patients with Hepatocellular Carcinoma Compared with Conventional Chemoembolization: A Propensity Score-Matched Study. SHILAP Revista de lepidopterología. Volume 8. 1565–1577. 11 indexed citations
10.
Chung, Sung Won, Min Kyung Park, Young Youn Cho, et al.. (2021). Effectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis. Journal of Hepatocellular Carcinoma. Volume 8. 587–598. 2 indexed citations
11.
Sugimoto, Katsutoshi, Dong Ho Lee, Jae Young Lee, et al.. (2021). Multiparametric US for Identifying Patients with High-Risk NASH: A Derivation and Validation Study. Radiology. 301(3). 625–634. 33 indexed citations
12.
Choi, Jae Won, Jeong Hee Yoon, Dong Ho Lee, et al.. (2021). No-Touch vs. Conventional Radiofrequency Ablation Using Twin Internally Cooled Wet Electrodes for Small Hepatocellular Carcinomas: A Randomized Prospective Comparative Study. Korean Journal of Radiology. 22(12). 1974–1974. 18 indexed citations
13.
Lee, Dae-Won, Eun Ju Cho, Su Jong Yu, et al.. (2020). Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib. Clinical Cancer Research. 27(3). 713–718. 33 indexed citations
14.
Lee, Dong Ho, Eun Sun Lee, Jae Young Lee, et al.. (2020). Two-Dimensional-Shear Wave Elastography with a Propagation Map: Prospective Evaluation of Liver Fibrosis Using Histopathology as the Reference Standard. Korean Journal of Radiology. 21(12). 1317–1317. 14 indexed citations
15.
Yoon, Jun Sik, Dong Ho Lee, Eun Ju Cho, et al.. (2020). Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance. Cancers. 12(7). 1805–1805. 25 indexed citations
16.
Yoo, Jeong‐Ju, Su Jong Yu, Bora Lee, et al.. (2019). Appraisal of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B. Gut and Liver. 14(3). 377–386. 1 indexed citations
17.
Kang, Seong Hee, Yun Bin Lee, Jeong‐Hoon Lee, et al.. (2017). Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy. Alimentary Pharmacology & Therapeutics. 46(9). 845–855. 61 indexed citations
18.
Woo, Hyun Goo, Ji Hye Choi, Sarah Yoon, et al.. (2017). Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer. Nature Communications. 8(1). 839–839. 88 indexed citations
19.
Cho, Hyeki, Yuri Cho, Eun Ju Cho, et al.. (2016). Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases. Clinical and Molecular Hepatology. 22(2). 286–291. 11 indexed citations
20.
Kim, Ji Won, Ji Bong Jeong, Su Jong Yu, et al.. (2007). Clinical Features and Therapeutic Responses of Abdominal Actinomycosis. Intestinal Research. 5(2). 177–183. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026